In our research, we demonstrated that RanGAP1 exhibited significant upregulation in CRC and served as a potential downstream effector of METTL3 and YTHDF1, undergoing m6A methylation modification to exert regulatory effects on the expression levels of RanGAP1. Here, METTL3 is linked to colorectal carcinoma.